BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30290838)

  • 21. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
    Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
    Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.
    Chen J; Li L; Liu TY; Fu HF; Lai YH; Lei X; Xu JF; Yu JS; Xia YJ; Zhang TH; Yang DJ; He YL
    Oncogene; 2022 Oct; 41(41):4591-4605. PubMed ID: 36068334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.
    Li Y; Wang NX; Yin C; Jiang SS; Li JC; Yang SY
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
    Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
    Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
    PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A-to-I editing of Malacoherpesviridae RNAs supports the antiviral role of ADAR1 in mollusks.
    Rosani U; Bai CM; Maso L; Shapiro M; Abbadi M; Domeneghetti S; Wang CM; Cendron L; MacCarthy T; Venier P
    BMC Evol Biol; 2019 Jul; 19(1):149. PubMed ID: 31337330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Song IH; Kim YA; Heo SH; Park IA; Lee M; Bang WS; Park HS; Gong G; Lee HJ
    Tumour Biol; 2017 Oct; 39(10):1010428317734816. PubMed ID: 29022489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
    Cho CJ; Myung SJ; Chang S
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
    Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N⁶-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.
    Visvanathan A; Patil V; Abdulla S; Hoheisel JD; Somasundaram K
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30781903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
    Nakano M; Fukami T; Nakajima M
    J Pharmacol Exp Ther; 2019 Sep; 370(3):408-415. PubMed ID: 31270214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.
    Wang Q; Hui H; Guo Z; Zhang W; Hu Y; He T; Tai Y; Peng P; Wang L
    RNA; 2013 Nov; 19(11):1525-36. PubMed ID: 24067935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.
    Zhang J; Chen Z; Tang Z; Huang J; Hu X; He J
    Tumour Biol; 2017 Jul; 39(7):1010428317708546. PubMed ID: 28714361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.
    Wang Q; Miyakoda M; Yang W; Khillan J; Stachura DL; Weiss MJ; Nishikura K
    J Biol Chem; 2004 Feb; 279(6):4952-61. PubMed ID: 14613934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.
    Chen T; Xiang JF; Zhu S; Chen S; Yin QF; Zhang XO; Zhang J; Feng H; Dong R; Li XJ; Yang L; Chen LL
    Cell Res; 2015 Apr; 25(4):459-76. PubMed ID: 25708366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
    Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
    Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
    Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
    Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.